ArticleImmunotherapy advances2023

Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key?

Katie R Flaherty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.